Multiple studies have shown the protective role of nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of antioxidative status, in the etiology and progression of NAFLD [30,31,32,33]. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.